AbbVie Inc.
GB ˙ LSE ˙ US00287Y1091
218,50 $ ↑6,00 (2,82%)
2026-06-03
AKTIENPREIS
SecurityGB:0QCV / AbbVie Inc.
InstitutionPatten Group, Inc.
Latest Disclosed Ownership1,489 shares
Latest Disclosed Value $ 323,843
Patten Group, Inc. reports 11.62% increase in ownership of 0QCV / AbbVie Inc.

On April 24, 2026 - Patten Group, Inc. filed a 13F-HR form disclosing ownership of 1,489 shares of AbbVie Inc. (GB:0QCV) valued at $322,398 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 1,334 shares of AbbVie Inc.. This represents a change in shares of 11.62% during the quarter. The current value of the position is $325,346 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F ABBVIE COM 00287Y109 1,489 155 11.62 324 6.25 0.0563
2026-01-23 2025-12-31 13F ABBVIE COM 00287Y109 1,334 0 0.00 305 -1.30 0.0564
2025-11-10 2025-09-30 13F ABBVIE COM 00287Y109 1,334 0 0.00 309 24.70 0.0601
2025-07-30 2025-06-30 13F ABBVIE COM 00287Y109 1,334 -26 -1.91 248 -13.03 0.0523
2025-05-14 2025-03-31 13F ABBVIE COM 00287Y109 1,360 -81 -5.62 285 10.94 0.0653
2025-02-06 2024-12-31 13F ABBVIE COM 00287Y109 1,441 -149 -9.37 256 -18.21 0.0567
2024-10-08 2024-09-30 13F ABBVIE COM 00287Y109 1,590 -141 -8.15 314 5.74 0.0697
2024-07-25 2024-06-30 13F ABBVIE COM 00287Y109 1,731 0 0.00 297 -6.03 0.0700
2024-04-17 2024-03-31 13F ABBVIE COM 00287Y109 1,731 -82 -4.52 315 12.50 0.0776
2024-01-10 2023-12-31 13F ABBVIE COM 00287Y109 1,813 -250 -12.12 281 -8.79 0.0763
2023-10-12 2023-09-30 13F ABBVIE COM 00287Y109 2,063 482 30.49 308 44.13 0.0919
2023-07-26 2023-06-30 13F ABBVIE COM 00287Y109 1,581 -10 -0.63 213 -15.81 0.0316
2023-04-06 2023-03-31 13F ABBVIE COM 00287Y109 1,591 300 23.24 254 21.63 0.0761
2023-02-10 2022-12-31 13F ABBVIE COM 00287Y109 1,291 1,291 209 0.0655
2022-10-13 2022-09-30 13F ABBVIE COM 00287Y109 0 -1,446 -100.00 0 -100.00
2022-07-18 2022-06-30 13F ABBVIE COM 00287Y109 1,446 0 0.00 220 -5.98 0.0705
2022-04-28 2022-03-31 13F ABBVIE COM 00287Y109 1,446 1,446 234 0.0656
2019-05-14 2019-03-31 13F AbbVie CS 00287Y109 0 -2,568 -100.00 0 -100.00
2019-02-12 2018-12-31 13F AbbVie CS 00287Y109 2,568 -181 -6.58 237 -8.85 0.1124
2018-11-14 2018-09-30 13F AbbVie CS 00287Y109 2,749 -115 -4.02 260 -1.89 0.0991
2018-08-13 2018-06-30 13F AbbVie CS 00287Y109 2,864 50 1.78 265 -0.38 0.1062
2018-05-11 2018-03-31 13F AbbVie CS 00287Y109 2,814 8 0.29 266 -1.85 0.1091
2018-02-02 2017-12-31 13F AbbVie CS 00287Y109 2,806 5 0.18 271 8.84 0.1073
2017-12-12 2017-09-30 13F/A-1 AbbVie CS 00287Y109 2,801 -19 -0.67 249 24.50 0.1007
2017-11-14 2017-09-30 13F AbbVie CS 00287Y109 843 -1,977 249 100,731.0078
2017-08-14 2017-06-30 13F AbbVie CS 00287Y109 2,820 -195 -6.47 200 1.01 0.0811
2017-05-30 2017-03-31 13F AbbVie CS 00287Y109 3,015 65 2.20 198 11.86 0.0859
2017-02-10 2016-12-31 13F AbbVie CS 00287Y109 2,950 -300 -9.23 177 -10.61 0.0794
2016-11-14 2016-09-30 13F AbbVie CS 00287Y109 3,250 0 0.00 199 -1.49 0.0933
2016-08-15 2016-06-30 13F AbbVie CS 00287Y109 3,250 0 0.00 201 8.65 0.0942
2016-05-13 2016-03-31 13F AbbVie CS 00287Y109 3,250 615 23.34 186 18.59 0.0881
2016-02-17 2015-12-31 13F AbbVie CS 00287Y109 2,635 -275 -9.45 156 -1.27 0.0750
2015-11-16 2015-09-30 13F AbbVie CS 00287Y109 2,910 0 0.00 158 -18.97 0.0815
2015-08-24 2015-06-30 13F AbbVie CS 00287Y109 2,910 2,910 196 0.0929
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.